Early memory phenotypes drive T cell proliferation in patients with pediatric malignancies

Science Translational Medicine

Volumn 8, Issue 320, 2016, Pages

  Singh, Nathan ^a   Perazzelli, Jessica ^b   Grupp, Stephan A ^b   Barrett, David M ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; INTERLEUKIN 15; INTERLEUKIN 7;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CELL EXPANSION; CELL LINEAGE; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE TECHNIQUE; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; INFANT; LONGITUDINAL STUDY; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MALE; MEMORY T LYMPHOCYTE; NONHODGKIN LYMPHOMA; OBSERVATIONAL STUDY; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; T CELL DEPLETION; T LYMPHOCYTE SUBPOPULATION; BLOOD; CELL PROLIFERATION; DRUG EFFECTS; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; NEOPLASMS; PATHOLOGY; T LYMPHOCYTE;

ADOLESCENT; CELL LINEAGE; CELL PROLIFERATION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOLOGIC MEMORY; INFANT; INTERLEUKIN-15; INTERLEUKIN-7; MALE; NEOPLASMS; PHENOTYPE; T-LYMPHOCYTES;

EID: 84954566107     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.aad5222     Document Type: Article

References (28)

1. H. Ekert, D. G. Jose, F. C. Wilson, R. N. Matthews, H. Lay, Intermittent chemotherapy and immunotherapy with BCG in remission maintenance of children with acute lymphocytic leukemia: Effects upon immunological function. Int. J. Cancer 16, 103-112 (1975).
2. R. Pettengell, H. Gurney, J. A. Radford, D. P. Deakin, R. James, P. M. Wilkinson, K. Kane, J. Bentley, D. Crowther, Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: A randomized controlled trial. Blood 80, 1430-1436 (1992).
3. Y. Komada, S. L. Zhang, Y. W. Zhou, M. Hanada, T. Shibata, E. Azuma, M. Sakurai, Cellular immunosuppression in children with acute lymphoblastic leukemia: Effect of consolidation chemotherapy. Cancer Immunol. Immunother. 35, 271-276 (1992).
4. C. L. Mackall, T. A. Fleisher, M. R. Brown, I. T. Magrath, A. T. Shad, M. E. Horowitz, L. H. Wexler, M. A. Adde, L. L. McClure, R. E. Gress, Lymphocyte depletion during treatment with intensive chemotherapy for cancer. Blood 84, 2221-2228 (1994).
5. C. L. Mackall, T. A. Fleisher, M. R. Brown, M. P. Andrich, C. C. Chen, I. M. Feuerstein, I. T. Magrath, L. H. Wexler, D. S. Dimitrov, R. E. Gress, Distinctions between CD8+ and CD4+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy. Blood 89, 3700-3707 (1997).
6. W. N. Haining, D. S. Neuberg, H. L. Keczkemethy, J. W. Evans, S. Rivoli, R. Gelman, H. M. Rosenblatt, W. T. Shearer, J. Guenaga, D. C. Douek, L. B. Silverman, S. E. Sallan, E. C. Guinan, L. M. Nadler, Antigen-specific T-cell memory is preserved in children treated for acute lymphoblastic leukemia. Blood 106, 1749-1754 (2005).
7. E. J. Wherry, V. Teichgräber, T. C. Becker, D. Masopust, S. M. Kaech, R. Antia, U. H. von Andrian, R. Ahmed, Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat. Immunol. 4, 225-234 (2003).
8. L. Gattinoni, E. Lugli, Y. Ji, Z. Pos, C. M. Paulos, M. F. Quigley, J. R. Almeida, E. Gostick, Z. Yu, C. Carpenito, E. Wang, D. C. Douek, D. A. Price, C. H. June, F. M. Marincola, M. Roederer, N. P. Restifo, A human memory T cell subset with stem cell-like properties. Nat. Med. 17, 1290-1297 (2011).
9. Y. Xu, M. Zhang, C. A. Ramos, A. Durett, E. Liu, O. Dakhova, H. Liu, C. J. Creighton, A. P. Gee, H. E. Heslop, C. M. Rooney, B. Savoldo, G. Dotti, Closely related T-memory stemcells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15. Blood 123, 3750-3759 (2014).
10. N. P. Restifo, L. Gattinoni, Lineage relationship of effector and memory T cells. Curr. Opin. Immunol. 25, 556-563 (2013).
11. S. L. Maude, N. Frey, P. A. Shaw, R. Aplenc, D. M. Barrett, N. J. Bunin, A. Chew, V. E. Gonzalez, Z. Zheng, S. F. Lacey, Y. D. Mahnke, J. J. Melenhorst, S. R. Rheingold, A. Shen, D. T. Teachey, B. L. Levine, C. H. June, D. L. Porter, S. A. Grupp, Chimeric antigen receptor T cells for sustained remissions in leukemia. N. Engl. J. Med. 371, 1507-1517 (2014).
12. D. L. Porter, B. L. Levine, M. Kalos, A. Bagg, C. H. June, Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia. N. Engl. J. Med. 365, 725-733 (2011).
13. M. L. Davila, I. Riviere, X. Wang, S. Bartido, J. Park, K. Curran, S. S. Chung, J. Stefanski, O. Borquez-Ojeda, M. Olszewska, J. Qu, T. Wasielewska, Q. He, M. Fink, H. Shinglot, M. Youssif, M. Satter, Y. Wang, J. Hosey, H. Quintanilla, E. Halton, Y. Bernal, D. C. G. Bouhassira, M. E. Arcila, M. Gonen, G. J. Roboz, P. Maslak, D. Douer, M. G. Frattini, S. Giralt, M. Sadelain, R. Brentjens, Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia. Sci. Transl. Med. 6, 224ra225 (2014).
14. J. N. Kochenderfer, M. E. Dudley, S. H. Kassim, R. P. T. Somerville, R. O. Carpenter, M. Stetler-Stevenson, J. C. Yang, G. Q. Phan, M. S. Hughes, R. M. Sherry, M. Raffeld, S. Feldman, L. Lu, Y. F. Li, L. T. Ngo, A. Goy, T. Feldman, D. E. Spaner, M. L. Wang, C. C. Chen, S.M. Kranick, A.Nath, D-A. N. Nathan, K. E. Morton, M. A. Toomey, S. A. Rosenberg, Chemotherapyrefractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor. J. Clin. Oncol. 33, 540-549 (2015).
15. D.W. Lee, J. N. Kochenderfer, M. Stetler-Stevenson, Y. K. Cui, C. Delbrook, S. A. Feldman, T. J. Fry, R. Orentas, M. Sabatino, N. N. Shah, S. M. Steinberg, D. Stroncek, N. Tschernia, C. Yuan, H. Zhang, L. Zhang, S. A. Rosenberg, A. S. Wayne, C. L. Mackall, T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: A phase 1 dose-escalation trial. Lancet 385, 517-528 (2015).
16. M. Kalos, B. L. Levine, D. L. Porter, S. Katz, S. A. Grupp, A. Bagg, C. H. June, T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia. Sci. Transl. Med. 3, 95ra73 (2011).
17. D. M. Barrett, N. Singh, X. Liu, S. Jiang, C. H. June, S. A. Grupp, Y. Zhao, Relation of clinical culture method to T-cell memory status and efficacy in xenograft models of adoptive immunotherapy. Cytotherapy 16, 619-630 (2014).
18. B. L. Levine, W. B. Bernstein, M. Connors, N. Craighead, T. Lindsten, C. B. Thompson, C. H. June, Effects of CD28 costimulation on long-term proliferation of CD4+ T cells in the absence of exogenous feeder cells. J. Immunol. 159, 5921-5930 (1997).
19. E. Lugli, M. H. Dominguez, L. Gattinoni, P. K. Chattopadhyay, D. L. Bolton, K. Song, N. R. Klatt, J. M. Brenchley, M. Vaccari, E. Gostick, D. A. Price, T. A. Waldmann, N. P. Restifo, G. Franchini, M. Roederer, Superior T memory stem cell persistence supports long-lived T cell memory. J. Clin. Invest. 123, 594-599 (2013).
20. N. Cieri, B. Camisa, F. Cocchiarella, M. Forcato, G. Oliveira, E. Provasi, A. Bondanza, C. Bordignon, J. Peccatori, F. Ciceri, M. T. Lupo-Stanghellini, F. Mavilio, A. Mondino, S. Bicciato, A. Recchia, C. Bonini, IL-7 and IL-15 instruct the generation of human memory stem T cells from naive precursors. Blood 121, 573-584 (2013).
21. G. Binotto, L. Trentin, G. Semenzato, Ifosfamide and cyclophosphamide: Effects on immunosurveillance. Oncology 65 (Suppl. 2), 17-20 (2003).
22. I. El-Serafi, M. Abedi-Valugerdi, Z. Potácová, P. Afsharian, J. Mattsson, A. Moshfegh, M. Hassan, Cyclophosphamide alters the gene expression profile in patients treated with high doses prior to stem cell transplantation. PLOS One 9, e86619 (2014).
23. H. Breithaupt, H. Pralle, T. Eckhardt, M. von Hattingberg, J. Schick, H. Löffler, Clinical results and pharmacokinetics of high-dose cytosine arabinoside (HD ARA-C). Cancer 50, 1248-1257 (1982).
24. M. Yabe, H. Yabe, S. Hamanoue, H. Inoue, M. Matsumoto, T. Koike, H. Ishiguro, T. Morimoto, S. Arakawa, T. Ohshima, A. Masukawa, H. Miyachi, T. Yamashita, S. Katob, In vitro effect of fludarabine, cyclophosphamide, and cytosine arabinoside on chromosome breakage in Fanconi anemia patients: Relevance to stem cell transplantation. Int. J. Hematol. 85, 354-361 (2007).
25. A. J.M. Ferreri, M. Reni, M. Foppoli,M.Martelli, G. A. Pangalis, M. Frezzato, M. G. Cabras, A. Fabbri, G. Corazzelli, F. Ilariucci, G. Rossi, R. Soffietti, C. Stelitano, D. Vallisa, F. Zaja, L. Zoppegno, G. M. Aondio, G. Avvisati, M. Balzarotti, A. A. Brandes, J. Fajardo, H. Gomez, A. Guarini, G. Pinotti, L. Rigacci, C. Uhlmann, P. Picozzi, P. Vezzulli, M. Ponzoni, E. Zucca, F. Caligaris-Cappio, F. Cavalli, High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: A randomised phase 2 trial. Lancet 374, 1512-1520 (2009).
26. D. Min, P. A. Taylor, A. Panoskaltsis-Mortari, B. Chung, D. M. Danilenko, C. Farrell, D. L. Lacey, B. R. Blazar, K. I. Weinberg, Protection from thymic epithelial cell injury by keratinocyte growth factor: A new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation. Blood 99, 4592-4600 (2002).
27. M. T. Kim, J. T. Harty, Impact of inflammatory cytokines on effector and memory CD8+ T Cells. Front. Immunol. 5, 295 (2014).
28. S. A. Grupp, M. Kalos, D. Barrett, R. Aplenc, D. L. Porter, S. R. Rheingold, D. T. Teachey, A. Chew, B. Hauck, J. F. Wright, M. C. Milone, B. L. Levine, C. H. June, Chimeric antigen receptor-modified T cells for acute lymphoid leukemia. N. Engl. J. Med. 368, 1509-1518 (2013).